OneTest for Cancer
Blood-based multi-cancer early detection LDT combining multiple serum tumor biomarkers with a machine-learning risk algorithm.
- Developer
- 20/20 GeneSystems
- Intended use
- Multi Cancer Screening
- Cancer scope
- Colorectal cancer, Liver cancer, Lung cancer, Prostate cancer
- Specimen
- Serum
- Molecular modality
- Protein
- Current version
- OneTest for Cancer current commercial LDT (2026)
- Evidence context
- 1 structured studies · 4 indexed performance results · 3 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.